High-Throughput Screening of Tyrosine Kinase Inhibitor Resistant Genes in CML
Department of Molecular, Cell and Cancer Biology; UMass Metabolic Network
Biochemistry | Cell Biology | Cellular and Molecular Physiology | Genomics | Molecular Biology
Genome-wide RNA interference (RNAi) screening in mammalian cells has proven to be a powerful tool for identifying new genes and molecular pathways relevant to many cellular processes and diseases. For example, screening for genes that, when inactivated, lead to resistance to cancer therapeutic drugs can reveal new mechanisms for how resistance develops and identify potential targetable strategies to overcome drug resistance. Here, we describe a detailed procedure for performing a high-throughput RNAi screen using a genome-wide human short hairpin RNA (shRNA) library for identifying tyrosine kinase inhibitor (TKI)-resistance genes in a human CML cell line model.
Rights and Permissions
Citation: Methods Mol Biol. 1 September 2016; 1465:159-73. doi: 10.1007/978-1-4939-4011-0_14. Link to article on publisher's site
CML, Drug resistance, Genome-wide, Imatinib, RNAi, Tyrosine kinase inhibitor, shRNA screen
Ma, Leyuan; Roderick, Justine E.; Kelliher, Michelle A.; and Green, Michael R., "High-Throughput Screening of Tyrosine Kinase Inhibitor Resistant Genes in CML" (2016). UMass Metabolic Network Publications. 61.